Lassonde Industries (LAS-A) Q4 2024 earnings summary

Executive summary

• Achieved record sales of over $2.6 billion and adjusted EBITDA of $276 million for 2024, with all divisions contributing to growth and strong U.S. volume gains despite a slight category decline.

• Canadian operations offset record orange juice inflation through pricing and innovation, while the Summer Garden acquisition bolstered specialty food segment growth.

• Strategic investments included new production lines, a $220 million multi-year U.S. expansion, and a new facility in New Jersey.

• Entering 2025 with cautious optimism, focusing on cost reduction, capacity improvement, and U.S. volume recovery.

Financial highlights

• Q4 2024 sales reached $738.1M, up 22% year-over-year; gross profit was $192.9M (26.1% margin), and adjusted EBITDA was $79.6M (10.8% margin), with adjusted EPS at $5.13.

• Full-year sales rose 12.4% to $2,600.9M; adjusted EBITDA was $275.8M (10.6% margin), and adjusted EPS was $19.05.

• Operating cash flow for 2024 was $233.9M, up from $220M; total dividend paid was $4.00 per share.

• Acquisitions (Summer Garden, Diamond) contributed $59.7M in Q4 sales.

• Q4 operating profit was $43.0M; fiscal 2024 operating profit was $174.7M.

Outlook and guidance

• 2025 sales expected to grow ~10% (excluding FX), driven by full-year Summer Garden contribution, price adjustments, and U.S. volume build-back.

• About half of 2025 revenue growth is acquisition-related; the rest split between volume and price increases.

• Gross margin faces Q1 pressure from apple concentrate cost spikes, but pricing actions in March expected to restore margins by Q2 if costs stabilize.

• Ongoing vigilance on commodity inflation, especially orange and apple concentrates; hedging in place for 70% of orange needs.

• CapEx to reach up to 9% of sales in 2025, mainly for U.S. facility investments, funded by operating cash flows.